Literature DB >> 23834725

Transient lymphopenia breaks costimulatory blockade-based peripheral tolerance and initiates cardiac allograft rejection.

S Iida1, T Suzuki, K Tanabe, A Valujskikh, R L Fairchild, R Abe.   

Abstract

Lymphopenia is induced by lymphoablative therapies and chronic viral infections. We assessed the impact of lymphopenia on cardiac allograft survival in recipients conditioned with peritransplant costimulatory blockade (CB) to promote long-term graft acceptance. After vascularized MHC-mismatched heterotopic heart grafts were stably accepted through CB, lymphopenia was induced on day 60 posttransplant by 6.5 Gy irradiation or by administration of anti-CD4 plus anti-CD8 mAb. Long-term surviving allografts were gradually rejected after lymphodepletion (MST = 74 ± 5 days postirradiation). Histological analyses indicated signs of severe rejection in allografts following lymphodepletion, including mononuclear cell infiltration and obliterative vasculopathy. Lymphodepletion of CB conditioned recipients induced increases in CD44(high) effector/memory T cells in lymphatic organs and strong recovery of donor-reactive T cell responses, indicating lymphopenia-induced proliferation (LIP) and donor alloimmune responses occurring in the host. T regulatory (CD4(+) Foxp(3+)) cell and B cell numbers as well as donor-specific antibody titers also increased during allograft rejection in CB conditioned recipients given lymphodepletion. These observations suggest that allograft rejection following partial lymphocyte depletion is mediated by LIP of donor-reactive memory T cells. As lymphopenia may cause unexpected rejection of stable allografts, adequate strategies must be developed to control T cell proliferation and differentiation during lymphopenia. © Copyright 2013 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  Costimulatory blockade; lymphopenia-induced proliferation; memory T cell

Mesh:

Year:  2013        PMID: 23834725      PMCID: PMC4216721          DOI: 10.1111/ajt.12342

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  46 in total

1.  CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.

Authors:  Cherry I Kingsley; Mahzuz Karim; Andrew R Bushell; Kathryn J Wood
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

Review 2.  Chronic rejection.

Authors:  P Libby; J S Pober
Journal:  Immunity       Date:  2001-04       Impact factor: 31.745

3.  Homeostatic proliferation is a barrier to transplantation tolerance.

Authors:  Zihao Wu; Steven J Bensinger; Jidong Zhang; Chuangqi Chen; Xueli Yuan; Xiaolun Huang; James F Markmann; Alireza Kassaee; Bruce R Rosengard; Wayne W Hancock; Mohamed H Sayegh; Laurence A Turka
Journal:  Nat Med       Date:  2003-11-30       Impact factor: 53.440

4.  Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance.

Authors:  Xin Xiao Zheng; Alberto Sánchez-Fueyo; Masayuki Sho; Christoph Domenig; Mohamed H Sayegh; Terry B Strom
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

5.  CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism.

Authors:  Zhenhua Dai; Qi Li; Yinong Wang; Ge Gao; Lonnette S Diggs; George Tellides; Fadi G Lakkis
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

6.  Potential role of host effector memory CD8+ T cells in marrow rejection after mixed chimerism induction in cynomolgus monkeys.

Authors:  Kiyoshi Setoguchi; Hidehiro Kishimoto; Sakiko Kobayashi; Hiroaki Shimmura; Hideki Ishida; Daisuke Toki; Toshihiro Suzuki; Kazunobu Ohnuki; Yoshiki Tate; Shigeru Fujioka; Ryo Abe; Kazunari Tanabe
Journal:  Transpl Immunol       Date:  2010-07-17       Impact factor: 1.708

7.  Prevention of kidney allograft rejection using anti-CD40 and anti-CD86 in primates.

Authors:  Krista G Haanstra; Jan Ringers; Ella A Sick; Seema Ramdien-Murli; Eva-Maria Kuhn; Louis Boon; Margreet Jonker
Journal:  Transplantation       Date:  2003-03-15       Impact factor: 4.939

8.  Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Authors:  Allan D Kirk; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Steven C Hoffmann; Robert L Kampen; Linda K Cendales; Douglas K Tadaki; David M Harlan; S John Swanson
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

9.  Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study.

Authors:  Stuart J Knechtle; John D Pirsch; John H Fechner; Bryan N Becker; Andreas Friedl; Robert B Colvin; Lauralynn K Lebeck; L Thomas Chin; Yolanda T Becker; Jon S Odorico; Anthony M D'Alessandro; Munci Kalayoglu; Majed M Hamawy; Huaizhong Hu; Debra D Bloom; Hans W Sollinger
Journal:  Am J Transplant       Date:  2003-06       Impact factor: 8.086

10.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Amrish C Ramsundar; Jobert G Barin; David A Kass; Noel R Rose
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

View more
  12 in total

1.  CD4 T Cell Help via B Cells Is Required for Lymphopenia-Induced CD8 T Cell Proliferation.

Authors:  Katayoun Ayasoufi; Ran Fan; Robert L Fairchild; Anna Valujskikh
Journal:  J Immunol       Date:  2016-02-24       Impact factor: 5.422

Review 2.  Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Expert Opin Biol Ther       Date:  2017-05-30       Impact factor: 4.388

3.  Prevalence and pathogenicity of autoantibodies in patients with idiopathic CD4 lymphopenia.

Authors:  Ainhoa Perez-Diez; Chun-Shu Wong; Xiangdong Liu; Harry Mystakelis; Jian Song; Yong Lu; Virginia Sheikh; Jeffrey S Bourgeois; Andrea Lisco; Elizabeth Laidlaw; Cornelia Cudrici; Chengsong Zhu; Quan-Zhen Li; Alexandra F Freeman; Peter R Williamson; Megan Anderson; Gregg Roby; John S Tsang; Richard Siegel; Irini Sereti
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 4.  Homeostatic expansion as a barrier to lymphocyte depletion strategies.

Authors:  Nicholas A Zwang; Laurence A Turka
Journal:  Curr Opin Organ Transplant       Date:  2014-08       Impact factor: 2.640

5.  Memory T Cells in Transplantation.

Authors:  Charles A Su; Robert L Fairchild
Journal:  Curr Transplant Rep       Date:  2014-09-01

6.  Depletion-Resistant CD4 T Cells Enhance Thymopoiesis During Lymphopenia.

Authors:  K Ayasoufi; R Fan; A Valujskikh
Journal:  Am J Transplant       Date:  2017-05-17       Impact factor: 8.086

7.  Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice.

Authors:  M L Miller; M D Daniels; T Wang; Y Wang; J Xu; D Yin; A S Chong; M-L Alegre
Journal:  Am J Transplant       Date:  2016-05-05       Impact factor: 8.086

Review 8.  Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.

Authors:  Joshua M Rosenblum; Allan D Kirk
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

9.  Change in lymphocyte to neutrophil ratio predicts acute rejection after heart transplantation.

Authors:  Dong-Hyun Choi; Yuhei Kobayashi; Takeshi Nishi; Helen Luikart; Sadia Dimbil; Jon Kobashigawa; Kiran Khush; William F Fearon
Journal:  Int J Cardiol       Date:  2017-10-22       Impact factor: 4.164

10.  Fifty Shades of Tolerance: Beyond a Binary Tolerant/Non-Tolerant Paradigm.

Authors:  Michelle L Miller; Anita S Chong; Maria-Luisa Alegre
Journal:  Curr Transplant Rep       Date:  2017-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.